Docusign Inc. $DOCU Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans decreased its position in shares of Docusign Inc. (NASDAQ:DOCUFree Report) by 34.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,351,714 shares of the company’s stock after selling 724,130 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Docusign were worth $97,445,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Twin Peaks Wealth Advisors LLC purchased a new stake in Docusign during the second quarter worth $43,000. First Horizon Advisors Inc. raised its stake in shares of Docusign by 48.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 590 shares of the company’s stock worth $46,000 after buying an additional 193 shares during the last quarter. SJS Investment Consulting Inc. boosted its position in shares of Docusign by 5,318.2% in the 3rd quarter. SJS Investment Consulting Inc. now owns 596 shares of the company’s stock worth $43,000 after buying an additional 585 shares in the last quarter. CX Institutional grew its stake in Docusign by 5,860.0% in the 3rd quarter. CX Institutional now owns 596 shares of the company’s stock valued at $43,000 after acquiring an additional 586 shares during the last quarter. Finally, Hantz Financial Services Inc. grew its stake in Docusign by 106.3% in the 2nd quarter. Hantz Financial Services Inc. now owns 848 shares of the company’s stock valued at $66,000 after acquiring an additional 437 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Transactions at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of the company’s stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the completion of the transaction, the chief executive officer owned 142,261 shares of the company’s stock, valued at approximately $9,901,365.60. This represents a 15.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total transaction of $804,360.00. Following the transaction, the insider directly owned 54,550 shares in the company, valued at approximately $3,656,486.50. This represents a 18.03% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 78,292 shares of company stock valued at $5,374,260 in the last quarter. Insiders own 1.01% of the company’s stock.

Docusign Stock Down 2.3%

Shares of NASDAQ:DOCU opened at $52.54 on Friday. The company has a market cap of $10.52 billion, a P/E ratio of 36.74, a P/E/G ratio of 2.64 and a beta of 0.99. The business has a fifty day simple moving average of $65.41 and a 200-day simple moving average of $70.93. Docusign Inc. has a 52 week low of $51.90 and a 52 week high of $99.30.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. reduced their price target on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Weiss Ratings restated a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Royal Bank Of Canada lowered their target price on Docusign from $95.00 to $70.00 and set a “sector perform” rating on the stock in a report on Monday, January 5th. Robert W. Baird dropped their price target on Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, December 5th. Finally, Cantor Fitzgerald restated an “outperform” rating on shares of Docusign in a research report on Wednesday, December 17th. Six analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $85.13.

View Our Latest Research Report on DOCU

Docusign Company Profile

(Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Further Reading

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.